Conferences and Meetings on Oncology

In this special program, world leaders in cancer research from Harvard and other internationally recognized institutes share their insights, and participants learn the new fundamentals of a wide spectrum of cancer science. You will gain the skills necessary to envision, design, and lead cutting-edge cancer research projects that can contribute to the diagnosis, prevention, and treatment of cancer. This year-long program is designed to help participants make high-impact contributions that lead to better cancer outcomes.

Email: CR@hms.harvard.edu

Harvard, mentor, cancer research, hybrid, workshops, webinars, comprehensive curriculum

This study day is aimed at dietitians, nurses, doctors and other healthcare professionals working with cancer patients. The world of cancer and nutrition is always changing with on-going research and exploration of this key area. This day will deliver sessions exploring what new evidence has emerged for a variety of cancer diagnosis and how this can be put into practice.

Conference Team;     Phone: [02078082921];     Email: conferenceteam@rmh.nhs.uk

International Academy for Clinical Hematology (IACH)

We are delighted to invite you to participate in the 2nd Annual Meeting of the International Academy for Clinical Hematology (IACH), taking place September 19-21, 2019 in Paris, France. The annual meeting of the IACH aims to create a comprehensive intellectual and operational environment for acquisition of knowledge, skills, clinical judgement, and attitudes essential for the practice of clinical hematology.

Email: moran@cme-congresses.com

Hematology Immune System

Hematology,    Stem-cell Research & Therapy

Welcome to The BIR HRCT portfolio where you can build evidenced learning on HRCT and rise ahead of your colleagues! The registration fees for this event includes all components required to complete the portfolio.

Phone: [02036682230];     Email: helen.omoregbee@bir.org.uk

Lung Diseases, case studies, pathological processes,

Radiology (in general),    Neuroradiology

The past few years have witnessed significant improvements in our understanding of lymphoproliferative malignancies and in our capabilities to treat patients diagnosed with these diseases. The introduction of new agents, including small molecules, non-conjugated and conjugated antibodies, and immunomodulation technologies (particularly chimeric antigen receptor T cells) has considerably changed the landscape of lymphoproliferative malignancies, with most patients achieving at least a durable response and even cure. The scientific program of the upcoming congress covers topics from all fields of clinical and laboratory aspects of chronic lymphocytic leukemia and lymphoma. World leaders in these fields will take part in this meeting and address new diagnostic technologies, current and future therapies. A special session will also be provided by leading experts in CAR T cells. The meeting will also provide a unique opportunity to meet colleagues from all over Europe, and serve as a platform for future collaborations.

Email: marc@bioevents-congress.com

lymphoproliferative malignancies, patients, new agents, small molecules, non-conjugated antibodies, conjugated antibodies, immunomodulation technologies, chimeric antigen receptor T cells, clinical, laboratory aspects, chronic lymphocytic leukemia, lymphoma, Hodgkin Lymphoma, large cell lymphoma, Biological Characteristics, C-MYC, BCL2, COO, Follicular lymphoma, MCL, ExtraNodal Lymphomas, PCNSL, MALT, Richter’s Syndrome, Waldens

The Cancer Research Institute (CRI), the Association for Cancer lmmunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to present the Fifth International Cancer lmmunotherapy Conference. The 2019 meeting will be held at the Espace Grande Arche in Paris, France from September 25 - 28, 2019. The program will focus on "Translating Science into Survival," and feature talks from more than 50 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy, including: regulating T cells and their response to cancer, tumor microenvironment, genetically engineered T cells, maintenance of immune balance, novel vaccine platforms and combinations, mutational analysis and predicting response to immunotherapy, convergence of technology and cancer immunotherapy, microbiome, and metabolism.

Email: info@cancerimmunotherapyconference.org

cancer prevention, combination therapies, immune checkpoint blockers, T cell exhaustion, immunotherapy, cellular therapy, tumor antigens, vaccines, tumor microenvironment, metabolism, microbiome, biologic therapy

Hilaris Conference invite you to be a part of the Oncology conference in Paris, France on September 26-27, 2019 to discuss on the new innovations within the field of Oncology for providing a much better moreover as a healthier life for the individuals from exceptionally prominent people and display of Standard universities. Hilaris Conference on Oncology 2019 pleased to be able to invite those of you ready to share their knowledge towards Oncology as well as those who are knowledge gaining aspirants in a single stage.

Phone: [+359-825-18874];     Email: oncologymeet@gmail.com

Three day course of systematic presentation of Head and Neck Oncology focusing on current concepts in surgery, radiation oncology and oncology. The program comprehends lectures, workshops, active cadaver preparations and life surgery. The course delivers current knowledge about standard procedures and controversies in Head and Neck Oncology like adjuvant treatment, induction chemo therapy, organ preservation and de-escalation concepts in HPV positive oropharyngeal cancer. Furthermore, functional aspects and surgical/phoniatric rehabilitation will be touched. Participants are integrated in active interdisciplinary discussions. Teaching in cadaver resections includes systematic in Neck dissection, laryngeal partial resection techniques and surgery and approaches to different sites of head and neck. In principle, the course will deliver concepts and raise awareness of evidence based modern Head and Neck Oncology. The Leipzig courses are well known for the very familiar and warm atmosphere among friends.

Das Programm ermöglicht die Aktualisierung des klinikrelevanten Wissens zur interdisziplinären Kopf-Hals-Onkologie. Hierbei stehen die Chirurgie und die konzeptuelle interdisziplinäre Therapieplanung im Vordergrund. Der Kurs wird in Deutsch und Englisch abgehalten. Lernziele sind die Vermittlung von unmittelbar umsetzbarem Wissen zur modernen Therapieentscheidung, Indikationsstellung zur operativen und medikamentösen Tumortherapie sowie die modernen Implikationen der Strahlentherapie. Der Kurs stellt die Sichtweise des Kopf-Hals-Chirurgen in den Vordergrund, der nach Maßgabe von John Drew Rich sich zum chirurgischen Kopf-Hals-Onkologen weiterentwickeln sollte. Präparationsübungen und interaktive Falldiskussionen in einer freundschaftlichen Atmosphäre geben dem Kurs die bislang exzellente Evaluation.

Phone: [+49(0)341/9721700];     Email: romy.wyrwas@medizin.uni-leipzig.de

Onkologie, Kopf-Hals-Onkologie, Kopf-Hals-Chirurgie

Otolaryngology,    Surgery

This one day course is aimed at all healthcare professionals, including nurses, doctors, GP's and pharmacists and any other clinicians caring for patients with a cancer diagnosis

Conference Team;     Phone: [02078082921];     Email: conferenceteam@rmh.nhs.uk

The theme of the conference is entitled “Interventional Therapy in Modern Oncology: Technological Integration Beyond Boundaries”. There will be over 100 world renowned international faculties and 50 national speakers from regionally renowned institutions, sharing their skills, knowledge and insight into case management and presenting the latest developments in the oncological fields. Live case transmission is among the highlight of the event. With the aim of Technological Integration in Oncology Beyond Boundaries, our delegates can expect to take away from this congress knowledge on new and effective treatment technologies in various new interventional options. Our goal is to give delegates information that they can take back and apply in their practice and optimize the treatment choices they can offer to patients. We invite our colleagues to share their work and research through free paper oral presentations and live e poster presentation sessions. Call for abstracts will open soon.

APCIO 2019 Secretariat;     Phone: [+603 2276 0555];     Email: secretariat@apcio2019.com

This year we hope to continue to provide an update on what is new, challenging and controversial in the management of patients with breast cancer. We will address the developing new frontiers of the management of brain metastases in Breast cancer, as well as the role of immunotherapy.

Phone: [02078082921];     Email: conferenceteam@rmh.nhs.uk

This activity provides updated and comprehensive coverage of selected topics in practical surgical pathology and cytopathology, including GI, liver, breast and gynecologic pathology and dermatopathology. It covers hematopathology and laboratory management and provides review and update on the most current diagnostic terminology and criteria, emphasizes diagnostic issues encountered in everyday practice, and offers practical strategies on how to recognize potential pitfalls and how to approach challenging cases in a systematic and logical way.

Phone: [9135887263];     Email: sthigpen2@kumc.edu

Pathology, Surgical Pathology, Anatomic Pathology, Cytopathology, Dermatopathology, Gynecologic pathology, Hematology, Oncology, GI Pathology, Liver Pathology, Breast Pathology, Laboratory Management, tumor staging

Medicine (in general),    Continuing Medical Education (CME)

The European Congress on Clinical Oncology (ECCO) will be held on Saturday October 5, 2019 in Frankfurt Germany. The congress will encompass all topics within the field of clinical oncology.

Phone: [+41 43 5082905];     Email: office@spg.ltd

Challenges in immunotherapy treatment NSSLC: Improving outcomes in advances stages New options for managing breast cancer Early cancer diagnosis biomarkers Rethinking clinical trial design

We invite you to join us at the 2nd joint EACR-MRS Conference on Seed and Soil: Mechanisms of Metastasis. This is a joint conference organised by the European Association for Cancer Research (EACR) and Metastasis Research Society (MRS).

Metastasis formation is responsible for over 90% of cancer patient deaths, largely due to the fact that therapies are generally ineffective against detectable metastatic tumors. There is thus a crucial need to mechanistically understand the cellular, tissue and whole-body processes driving metastasis formation in order to identify effective therapeutic strategies. This conference will give an in-depth overview of our current knowledge on cancer, stromal and immune cell centred mechanisms promoting metastasis formation presented by world-leading researchers in the field.

Phone: [0115 951 5065];     Email: l.strachan@nottingham.ac.uk

cancer, tumor, tumour, metastasis, therapeutic, stromal, immune, cell, research, therapy, treatment, oncology

Oxford Global are proud to present the 2nd Annual Advances in Immuno-Oncology USA Congress, 8 - 9 October 2019, San Diego, USA. Join over 200 delegates from global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions. Over 40 presentations, case studies and panel discussions focusing on the latest innovations in Immuno-Oncology therapy development, patient stratification and clinical tools and research.

Phone: [+44 (0)1865 248455];     Email: a.saez@oxfordglobal.co.uk

Immuno-Oncology, CAR T-Cell Therapy, Clinical Oncology, Immunotherapy, Oncology Biomarkers

Surgery,    Cardiology

Surgery,    Pulmonology

It is great pleasure that we invite you to participate in this very exciting conference on Kidney and Prostate cancer. Both are diverse diseases ranging from small clinically insignificant tumours to advance incurable malignancy.

Phone: [02078082921];     Email: conferenceteam@rmh.nhs.uk

Urology, Andrology,    Nephrology

Preponderant experimental and clinical evidence has demonstrated that pervasive cancer cell heterogeneity in both phenotypic presentations and functional properties exists, such that a population of cancer cells with cardinal stem cell properties (i.e., cancer stem cells) pre-exists in untreated tumors and spatiotemporally evolves during tumor progression and therapeutic interventions. Recent studies have also revealed significant phenotypic and functional plasticity in cancer cells, regulated by both genetic networks and epigenetic mechanisms. Both cancer cell heterogeneity and plasticity constitute major barriers to efficient and durable clinical treatments. Ever since the revival of the cancer stem cell research field around the turn of the century, we have made great strides in identifying and elucidating the biology of cancer stem cells in virtually all tumor systems. Significant progress has also been made in understanding how cancer stem cells interact with the cellular constituents and soluble factors in the proinflammatory and immune-suppressive tumor microenvironment. Facilitated by an explosion of technical advances in recent years, especially single-cell RNA-seq, we are achieving an unprecedented appreciation of the complexity of the cellular heterogeneity of human tumors. Significantly, novel therapeutic strategies that target cancer stem cells and cancer cell heterogeneity and plasticity are rapidly progressing to the clinical arena. This conference is organized to recapitulate these recent advances in our understanding of cancer stem cell biology and, importantly, the clinical translation of targeting cancer stem cells.

Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org

stem cells, cancer, regenerative medicine, development

Stem-cell Research & Therapy,    Biology

This conference will focus on new clinical outcomes data, innovative treatment delivery and management approaches, and the latest advances in proton therapy.

Phone: [786-596-2398];     Email: juliez@baptisthealth.net

Proton Therapy conference; Radiation Oncology Conference; Oncology CME; Proton Therapy CME

Phone: [408-352-1010];     Email: info@2019crtc.com

Cancer Biomarkers 2 Cancer Gene Therapy 3 Cancer Nursing 4 Clinical Oncology 5 Pediatric Oncology 6 Radiation, Surgical and Medical oncology 7 Cancer Genetics 8 Breast Cancer Research 9 Cancer Stem Cell Therapy 10 Innovations in prevention and screening 11 Anti-Cancer Drug Discovery & Therapy 12 Cancer Screening & Diagnosis 13 Cancer Immunology & Vaccines 14 Organ Specific Cancers and Effects

The 8th Conference of IAOC "Current Status and Future of Anti-Cancer Therapies" will be held in Buenos Aires, Argentina in October 17th and 18th, 2019. An outstanding faculty of speakers from the United States and Europe has committed in this meeting. The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types. The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies and emerging treatments in early development. The major emphasis will be on clinical aspects of cancer treatment in the 21st century with discussion of significant scientific advances underlying the novel approaches still in preclinical development.

This meeting is the primary opportunity for oncologists, hematologists and cancer related health workers to participate in a conference focusing on novel targeted therapies and other treatment advances which are changing the face of cancer care.

Secretariat;     Email: secretariat@oncologyconferences.com.ar

NEW ANTICANCER THERAPIES, MELANOMA, BREAST CANCER, GU CANCER, PROSTATE AND RENAL CANCER, BLADDER CANCER, GI CANCER, LUNG CANCER, HEMATOLOGICAL MALIGNANCIES, LYMPHOMA, LEUKEMIA, MULTIPLE MYELOMA

Excellence in Oncology Care Congress 2019 to be held on 17 – 19 October 2019, complements the objective of the local & regional healthcare authorities to continually provide training, conferences and workshops specifically in the field of Oncology.

Phone: [+97145208888];     Email: tanaya.priya@index.ae

Breast Oncology, Breast Surgical, Imaging, GI Oncology, Gynae Oncology, Lung Oncology, Oncology Nursing, Palliative Care, Immuno Oncology, Head & Neck Oncology, Uro Oncology, Nutrition, Molecular Tumor Board, Oncology Care

Surgery,    Pulmonology

United Scientific Group (A Non-Profit Organization) hosted three events still now on Cancer Research and Targeted Therapy twice in USA and once in UK. Having a total of 200 participants and their positive notes we are happy to announce our next event the fourth edition of Cancer Research & Drug Development at the largest independent city Baltimore USA this October 21-23, 2019.

Phone: [+1-408-426-4832];     Email: cancer.therapy@uniscigroup.org

Cancer Metastasis, Cancer Resistance, Cancer Microenvironment, Novel Therapeutics target in Cancer, Cancer drug development, Cancer Immunotherapy, Cancer Targeted Therapy, Cancer Nanomedicine, Cancer Radiation Therapy, Cancer Genetics, Breast Cancer, Uterine Cancer, Lung Cancer, Hematological Cancer, Sarcoma.

Since the inaugural Congress in 2001, this meeting has become the premier forum for discussion on the latest advances in myeloproliferative neoplasms (MPNs). This year, the Congress will focus on timely topics of interest to hematologists and oncologists who treat patients with these rare disorders. The Congress program format will utilize case presentations to highlight the essential features of MPN pathophysiology, diagnosis and management, as well as the roles of next generation sequencing and the MPN driver mutation and allele burden in clinical decision making. In addition to defining the role of pegylated interferon and its long-acting derivatives in MPN therapy, the role of immunotherapy in the MPNs and novel agents for MPN treatment will be reviewed. New this year will be a discussion of the management of accelerated and blast phase MPN, patient selection for bone marrow transplantation, and how to integrate MPN patient symptom scores with therapeutic planning. The program features a world class faculty and highly interactive sessions designed to engage participants and provide a state-of-the-art learning experience.

Phone: [512-619-5534];     Email: info@meltonmeded.com

myeloproliferative neoplasms, MPN, polycythemia vera, PV, essential thrombocythemia, ET, myelofibrosis, MF, PMF, Chronic myeloid leukemia, CML, CNL, mastocytosis, hematopoiesis

Hematology,    Continuing Medical Education (CME)

Surgery,    Continuing Medical Education (CME)

Over 600 delegates are expected to attend the SynGen Series UK, representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading global pharmaceutical organisations and biotech companies.

Phone: [+441865248455];     Email: d.dalby@oxfordglobal.co.uk

Digital PCR. NGS, Single Cell Analysis, Genome Editing, Synthetic Biology, DPCR, Cancer, Infectious Disease Diagnosis, Next Generation Sequencing & Clinical Diagnostics, Single Cell Analysis, PCR, QPCR, Oncology

Genomics and Bioinformatics,    Pharmacology and Drug Development

Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer

MAP 2019 - Molecular Analysis for Personalised Therapy is a unique meeting established by global opinion leaders. The congress aims to integrate insights from tumour sample analysis into daily practice. The MAP Congress has grown into an influential, highly interactive forum which is a natural choice for specialists working in precision medicine in oncology. The Congress programme is based on the genomic information obtained through the sequencing of all tumours and the tumour environment.

Phone: [+41 91 97 31 947];     Email: meetings@esmo.org

oncology, personalised medicine, precision medicine, genome alterations, genome sequencing, molecular analysis

Pharmacogenomics, Personalized Medicine,    Translational Medicine, Clinical Trials

After the success of the last ten years, it is with great pleasure that you are invited to participate in the eleventh Royal Marsden Head and Neck Conference. The meeting will be of particular interest to maxilliofacial, ENT or plastic surgeons with an interest in head and neck oncology, as well as clinical/medical oncologists, radiologists and pathologists.

Phone: [02078082921];     Email: conferenceteam@rmh.nhs.uk

Palliative Surgey, pre-frailty and frailty, biology of the ageing cell, end of life care,

The Jefferson Thyroid Cancer and Parathyroid Disease Update 2019: Updates in Diagnosis and Treatment offers participants a unique opportunity to witness experts deliberate and debate how they would manage a patient’s thyroid cancer and parathyroid diseases. This active learning format features critical deliberations ​​​​​​​regarding patient cases, clinical findings, differential diagnoses, and management plan options. Participants will examine cases from multiple perspectives, and gain an in-depth understanding of how experienced healthcare providers approach difficult patient care decisions. Keynote Lectures from leading practitioners provide evidence for care decisions discussed in panels which will increase confidence in diagnostic and treatment decision making for participants.

Phone: [(215) 955-6992];     Email: jeffersoncpd@jefferson.edu

Endocrinology, Family Medicine, Oncology, Otolaryngology, Radiology, Surgery

Der Hämato/Onko Refresher findet vom 08. - 09. November 2019 in Berlin statt. In kurzen, 30 – 45 minütigen Vorträgen werden die neuesten diagnostischen und therapeutischen Leitlinien der Hämatologie und Onkologie von Spezialisten präsentiert und auf Ihre Fragen eingegangen. Dabei wird vor allem auf Praxisrelevanz großen Wert gelegt.

Forum für medizinische Fortbildung;     Phone: [+49 (0) 6192 957 89 41];     Email: info@fomf.de

Hämatologie, Onkologie

Hematology,    Continuing Medical Education (CME)

The 4th edition of this highly successful conference will focus on the latest advances in 3D-based cellular models and emerging topics in the areas of cell architecture, mechanobiology, the immune microenvironment, high level imaging and high-content analysis for cancer therapeutics. The conference format is designed to encourage networking in order to develop approaches that translate to outcomes.

Phone: [0115 951 5065];     Email: roger.doxat-pratt@nottingham.ac.uk

cancer, oncology, research, cell adhesion, migration, mechanics, tumour invasion, 3D, in vitro, drug development, multicellular, immune, microenvironment, culture, mechanobiology

This event will provide an overview of cancer immunotherapy, with a focus on the recognition and management of immune-mediated toxicities. The meeting will have a strong clinical emphasis, aimed at providing delegates with practical guidance that can be utilised in daily practice.

Phone: [02078082921];     Email: conferenceteam@rmh.nhs.uk

Group Futurista

Future of Personalized Medicine Summit for Oncology is a 2-day networking event with revolutionary keynotes, case studies, and panels. It brings together experts from the fields of Pharmaceutical, Biotechnology, Hospitals, and Academics to discuss how AI and Blockchain technologies are impacting the Future of Medicine. A one of a kind forum to benchmark, gain subject matter expertise & business intelligence by collaborating with industry leaders from the field of Engineering, Diagnostics, Bioinformatics, Drug Discovery, Therapies and more!

Email: jennifer@groupfuturista.com

oncology events, personalized healthcare, precision medicine, precision oncology

ABC has established itself as a major international breast cancer conference. Its primary aim is the development of international consensus guidelines for the management of advanced breast cancer patients. These treatment guidelines are based on the most up-to-date evidence and can be used and adapted to many different health care settings globally.

Phone: [+39 02 8546451];     Email: communication@eso.net

Breast cancer, Adcanced breast cancer, Metastatic breast cancer

Der Hämato/Onko Refresher findet vom 15. - 16. November 2019 in Stuttgart statt. In kurzen, 30 – 45 minütigen Vorträge werden die neuesten diagnostischen und therapeutischen Leitlinien der Hämatologie und Onkologie von Spezialisten präsentiert und auf Ihre Fragen eingegangen. Dabei wird vor allem auf Praxisrelevanz großen Wert gelegt.

Forum für medizinische Fortbildung;     Phone: [+49 (0) 6192 957 89 41];     Email: info@fomf.de

Hämatologie, Onkologie

Hematology,    Continuing Medical Education (CME)

PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. In 2018, more than 1,100 delegates from 36 countries, including 70% from pharma and biotech organizations, convened in beautiful Lisbon, Portugal to discuss the latest advances in protein and antibody engineering. The 2019 event will feature 1,300 attendees, 260 speakers, 25 problem-solving breakout discussions, 250 scientific posters, 100+ industry-leading sponsors and exhibitors, and countless networking opportunities.

Email: asaenger@healthtech.com

Engineering, Oncology, Immunotherapy, Expression, Analytical, antibody engineering, protein engineering, bispecifics, biotherapeutics

Biotechnology,    Genomics and Bioinformatics

The Sixth Royal Marsden lung cancer symposium will tackle burning issues and key challenges facing clinicians treating patients with lung cancer. We have assembled a combination of highly knowledgeable faculty members who will be talking on topics including, lung cancer screening, biomarker testing, systemic and local therapies in both NSCLC and SCLC.

Phone: [02078082921];     Email: conferenceteam@rmh.nhs.uk

This study day will explore aspects of contemporary haemato-oncology practice delivered by a variety of clinicians working within the specialty.

Conference Team;     Phone: [02078082921];     Email: conferenceteam@rmh.nhs.uk

The programme will be educational and empowering, covering a wide variety of topics presented by some of the leading experts in their field. The day will consolidate and build on your existing knowledge when caring for this complex group of women.

Conference Team;     Phone: [02078082921];     Email: conferenceteam@rmh.nhs.uk

Der Hämato/Onko Refresher findet vom 29. - 30. November 2019 in Köln statt. In kurzen, 30 – 45 minütigen Vorträgen werden die neuesten diagnostischen und therapeutischen Leitlinien der Hämatologie und Onkologie von Spezialisten präsentiert und auf Ihre Fragen eingegangen. Dabei wird vor allem auf Praxisrelevanz großen Wert gelegt.

Forum für medizinische Fortbildung;     Phone: [+49 (0) 6192 957 89 41];     Email: info@fomf.de

Hämatologie, Onkologie

Hematology,    Continuing Medical Education (CME)

International Congress of Cancer & Clinical Oncology (CCCO-2019) will be held from December 5-7, 2019 in Grand Copthorne Waterfront Hotel Singapore.

CCCO-2019 mainly focuses on current hot topics of cancer research and clinical oncology to accelerate the translation of cutting edge discovery from basic science to clinical level, and further promote international scientific cooperation, debate and exchange. It aims to presents a unique platform for prominent surgeons, doctors, academician, scientists and R&D leaders from pharmaceuticals to obtain and exchange information on advances in the basic research, early diagnosis and treatment of cancer, while considering both global and regional aspects.

Phone: [00852-37194236];     Email: Cecilia@istci.org

Cancer Molecular Biology & Genetics, Cancer Immunology & Immunotherapy, Cancer Prevention and Epidemiology, Cancer Pharmacology, Cancer Screening & Diagnosis, Cancer Metastasis, Cancer Precision Medicine, Cancer Biomarkers, Gastrointestinal Cancer, Gynecologic Cancer, Head & Neck Cancers, Lung Cancer, Blood and Lymphatic Cancers, Radiation and Medical Oncology, Robotic and AI in Surgical Oncology, Liver, Cholecyst and Pancreatic Cancer

The Miami Brain Symposium will focus on state-of-the-art approaches in the management of primary and metastatic brain and spine tumors, along with an understanding of current standards of care as well as a look at future directions. For one full day this symposium will engage participants, as the expert faculty navigate through complex cases and novel treatment strategies and lively panel discussions.

Phone: [786-596-2398];     Email: JulieZ@BaptistHealth.net

Neurooncology CME, Neurooncology Conference, Baptist Health CME, Miami Brain Symposium

Neurology,    Neuroradiology

460,000 new cases of pancreatic cancer in 2018. The congress will focus on translational and clinical pancreatic cancer research including sessions on diagnostics, screening and therapy. Additional topics such as genetic testing, immunology and immunotherapy, management of local disease, etabolism and metabolomics, precision medicine, signaling and oncogenes as well as the tumor microenvironment will be presented.

Martel Sylvie;     Phone: [04 95 09 38 00];     Email: sylvie.martel@mcocongres.com

Pancreas Cancer Oncology Immunology Immunotherapy Endocrinology

Unique in Europe, the TOW (Toulouse Onco Week) invites you to its third edition, from February 1st to 5th, 2020! Organized as part of the World Cancer Day, TOW is unique as to bring together the different actors from research, care, industry and charities in order to better fight cancer. In February 2018, this meeting brought together more than 2 000 participants and was the opportunity for a strong mobilization of the medical and scientific community and hopeful announcements.

Insight Outside;     Email: contact@toulouse-onco-week.org

Can we really improve DNA damaging agents efficacy? Targeted therapies and resistance mechanisms Translating oncoimmunology science into survival Metabolic vulnerabilities–driven therapies

Unique en Europe, la TOW (Toulouse Onco Week) vous donne rendez-vous pour sa troisième édition, du 1er au 5 février 2020! Organisée dans le cadre de la journée mondiale contre le Cancer, la TOW a la particularité de fédérer les acteurs scientifiques, médico-soignants, industriels et associatifs pour mieux combattre le cancer. En février 2018, cette rencontre a réuni plus de 2000 participants et a été l’occasion d’une forte mobilisation de la communauté médico-scientifique et d’annonces porteuses d’espoir.

Phone: [0585954554];     Email: soizic@toulouse-onco-week.org

Can we really improve DNA damaging agents efficacy? Targeted therapies and resistance mechanisms Translating oncoimmunology science into survival Metabolic vulnerabilities–driven therapies

ESMO’s Sarcoma & GIST Symposium is a highly specialised meeting bringing together the most brilliant medical minds working on these tumour types. The Symposium is known as the place of choice for international networking and collaboration, featuring discussions with the key opinion leaders in these rare sub-entities.The Symposium brings translational researchers and clinicians together and builds on an integrated approach for improved patient outcomes.

Phone: [+41 91 97 31 939];     Email: registration@esmo.org

sarcoma, gist, gastrointestinal stromal tumours, rare cancers, translational research, oncology, cancer, soft tissue sarcomas, medical oncology, surgical oncology, radiotherapy, pathology

Evading programmed cell death is a major hallmark of cancer cells and contributes to tumor progression and therapy resistance. Emerging hallmarks such as metabolic plasticity, genomic instability and an immunosuppressive tumor environment allow the tumors to escape from standard cytotoxic as well as targeted therapies. Thus, understanding the underlying mechanisms in appropriate pre-clinical/clinical models is crucial for the design of more effective combination therapies to avoid treatment failure or tumor recurrence. The EACR Special Conference “A Matter of Life or Death: Mechanisms, Models and Therapeutic Opportunities” is the 5th Conference on this topic. Its objective is to cover recent and exciting developments in the field of cancer research that are crucial to our understanding of the multifaceted role of cell death in tumor initiation, progression and therapy response.

The 4th DNA Repair/Replication Structures & Cancer conference in February 2020 will focus on structural and mechanistic insights into dynamic protein, chromatin, DNA and RNA complexes acting in DNA repair and its interface with DNA replication and transcription events relevant to cancer. This fundamental information will be pivotal for the accurate interpretation of cancer clinical data, design of clinical trials, prognosis, etiology and improving the currently 1/20 low success rate for oncology drug clinical trials. Informative talks and poster sessions along with vibrant discussions will foster productive interactions and collaborations.

Conference Manager;     Phone: [+441638724137];     Email: admin@fusion-conferences.com

DNA, DNA Repair, DNA replication, RNA, Cancer, DNA damage signaling, cross-talk, Epigenetics, PARP, PARG, metabolic signalling, Mitochondrial replication, apoptosis

Molecular Biology,    Biology

Der DKK 2020 steht unter dem Motto informativ. innovativ. integrativ. Optimale Versorgung für alle.

Phone: [+49 3643 2468-0];     Email: info@kukm.de

Secretariat;     Phone: [+82-2-566-6031];     Email: ik2020@iasgo-ksgc2020.org

Esophagus, Stomach, Colon, Pancreas, Liver and Bile Duct, Small Intestine, Basic Translation, Others

Gastroenterology,    Surgery

EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO)

This EACR-AACR-ASPIC conference on Tumor Microenvironment(TME) will bring together thought leaders spanning the breadth of TME, immune-oncology, computational biology and biomedical technology disciplines to discuss novel approaches to identify critical mechanisms regulating the crosstalk in these tumor ecosystems.

Email: hello@eaa2020.org

Tumour Microenvironment, Immune-oncology, Computational biology

The 3rd International Cancer Congress (ICC 20) is an educational meeting intended to improve the care of cancer patients in South Asia by educating cancer care providers about the latest developments in the field of cancer, and their applications in local context. This international hematology and oncology conference will feature renowned faculty from the United States, Nepal, and other parts of the world.

The aim of the study day is to facilitate and equip attendees with the knowledge and skills to care for those with communication and swallowing disorders as a result of their oncological diagnosis or treatment.

Conference Team;     Phone: [02078082921];     Email: conferenceteam@rmh.nhs.uk

Knowing how cells respond to DNA damage is critical to our understanding of tumourigenesis, genomic instability, and the cellular response to DNA-damaging chemotherapy and radiotherapy. DNA damage responses take place in the context of chromatin and in the midst of ongoing transcription and replication. Moreover, the metabolic environment, which is altered in tumour cells, influences these activities. In this conference, we aim to bring together researchers working on understanding DNA damage responses in the context of complex and dynamic cellular environments. This is an exciting and fast moving area, and this conference features an excellent international line-up of speakers. The programme will address the challenges of understanding this complex field and will emphases new experimental approaches for interrogating these pathways. We will also consider how recent advances can be exploited in the clinic.

DNA damage responses, cancer, oncology, Epigenetic, radiotherapy, transcription, immune, repair, tumourigenesis, cellular, genomic

Over the last few years, the myeloma field has made significant progresses. We have seen fascinating novel drugs being introduced (including innovative cellular therapies), and the whole treatment paradigm is progressively changing.

Like the previous ones, this international meeting aims to deliver state of the art science and research, focused on the latest advances in the field and on improving patient care.

The scientific content will be on the cutting-edge one because the pace of change in multiple myeloma is accelerating.

In addition to the science, you will be able to enjoy this most spectacular city of Paris. We are looking forward to seeing you in Paris next year

Phone: [+972528887612];     Email: moran@cme-congresses.com

Multiple Myeloma, cancer, CAR T Cell

Hematology,    Continuing Medical Education (CME)

Molecular pathology is revolutionising clinical practice in oncology and pathology paving the way for precision medicine, and has evolved into a growing research field. Knowledgeable molecular pathologists are a significant bottle neck for advancing cancer research and patient care. This meeting will provide participants with a broad view of the scope, methodologies, future directions and challenges in addition to practical approaches for molecular pathology in research and in clinical settings. The potential uses of deep learning in pathology will be discussed. The meeting will help participants to establish a network of interactions and to build bridges to foster cross disciplinary studies. We are preparing for the future and for the unknown discoveries still to come.

Email: laura.strachan@eacr.org

Molecular pathology, cancer research, oncology

EACR 2020 is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.

Email: hello@eacr2020.org

Artificial Intelligence, Cancer Genomics, Immuno Genomics, Cancer Models, Metastasis, Lineages, DNA Damage, Vital Imaging, Metabolism, Microbes

Phone: [+4936413116390];     Email: conferencemarketing@conventus.de

Phone: [+4936413116390];     Email: conferencemarketing@conventus.de

Phone: [+4936413116390];     Email: julia.wrenczycki@conventus.de